OPUS GENETICS INC. - COMMON STOCK
1.1800
01-11月-24 15:59:56
15 分の遅延
株式
-0.0200
-1.67%
本日の幅
1.1600 - 1.2185
ISIN
N/A
ソース
NASDAQ
-
Ocuphire Pharma Announces Acquisition of Opus Genetics
22 10 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
30 9 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
05 9 2024 20:43:59 提供 Nasdaq GlobeNewswire
-
05 9 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for Second Quarter 2024 and Provides Corporate Update
13 8 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at Two Investor Conferences in August
08 8 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma to Highlight APX3330 for Diabetic Retinopathy at Two Scientific Meetings in July
10 7 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
06 6 2024 07:57:22 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for First Quarter 2024 and Provides Corporate Update
10 5 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Presentation on APX3330 at the ARVO 2024 Annual Meeting
06 5 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at the Aegis Virtual Conference
03 5 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces APX3330 Presentation at ARVO 2024 Annual Meeting
22 4 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
01 4 2024 07:14:52 提供 Nasdaq GlobeNewswire
-
08 3 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present in the BIO CEO & Investor Conference
23 2 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
15 2 2024 16:10:00 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma Strengthens Leadership Team with Key Appointments
14 2 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
05 2 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Ocuphire Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
24 1 2024 16:10:00 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >